{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:25:26Z","timestamp":1792041926953,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The southwest medical universit","award":["2016217"],"award-info":[{"award-number":["2016217"]}]},{"DOI":"10.13039\/501100019971","name":"Luzhou science and Technology Bureau","doi-asserted-by":"crossref","award":["16188"],"award-info":[{"award-number":["16188"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anti-M\u00fcllerian hormone (AMH) is secreted by granulosa cells in preantral follicles and small antral follicles. There is limited information about whether serum AMH levels are related to pregnancy outcomes during in vitro fertilization and embryo transfer (IVF-ET). The aim of this study was\u00a0to provide a theoretical basis for improving pregnancy outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted on infertile women who were treated at the Reproductive Centre of the Affiliated Hospital of Southwest Medical University between September 2018 and September 2019. The sample included 518 participants from Southwest China. The participants were divided into 2 groups according to their AMH level. Their data were retrieved from the medical records: days and dosage of gonadotropin (Gn) (one bottle equals 75\u00a0IU), the number of oocytes obtained, the number of oocytes in metaphase II (MII) and the number of high-quality embryos. The pregnancy outcomes were followed up and divided into two groups according to whether they were pregnant or not, with statistical analysis of the parameters related to the in vitro fertilization process performed separately.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to a lower AMH level (AMH\u2009\u2264\u20091.1), a higher AMH level (AMH\u2009&gt;\u20091.1) resulted in less total Gn (bottle) (P\u2009=\u20090.00\u2009&lt;\u20090.05) and a lower starting Gn (IU) (P\u2009=\u20090.00\u2009&lt;\u20090.05), while the number of oocytes obtained,MII,cleavages and high-quality embryos were higher (P\u2009=\u20090.00\u2009&lt;\u20090.05). The participants' pregnancy outcomes (ectopic pregnancy, miscarriage, singleton, twin, multiple births) were found to not be predictable by AMH through ROC curves (P\u2009=\u20090.980, 0.093, 0.447, 0.146, 0.526, and 0.868\u2009&gt;\u20090.05). For participants in the pregnancy group, although AMH was lower in the nonpregnant participants(P\u2009=\u20090.868\u2009&gt;\u20090.05), the difference was not statistically significant, and the correlation coefficients between the two groups suggested no differences in the IVF process, except for the starting Gn (IU) (P\u2009=\u20090.038\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>AMH has clinical application value in predicting ovarian reserve function, providing guidance and suggestions for the specific formulation of ovulation promotion programs with assisted reproductive technology, but it cannot effectively predict the outcome of clinical pregnancy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12978-022-01524-5","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T16:21:16Z","timestamp":1670948476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Predictive value of anti-Mullerian hormone for pregnancy outcomes following assisted reproductive techniques (ART) in Southwest China","Pr\u00e4diktiver Wert des Anti-Mullerian-Hormons f\u00fcr Schwangerschaftsergebnisse nach assistierten Reproduktionstechniken (ART)im S\u00fcdwesten Chinas"],"prefix":"10.1186","volume":"19","author":[{"given":"Ling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Jian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-0410","authenticated-orcid":false,"given":"Yun-Zhu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"1524_CR1","doi-asserted-by":"publisher","unstructured":"Chang HM, Zhu YM, Leung PCK. Chapter 7 - Cell-cell interactions in ovarian follicles: role of TGF-\u03b2 superfamily members. The Ovary (Third Edition). 2019:107\u2013125. https:\/\/doi.org\/10.1016\/B978-0-12-813209-8.00007-8.","DOI":"10.1016\/B978-0-12-813209-8.00007-8"},{"key":"1524_CR2","first-page":"94","volume":"39","author":"M Zheng","year":"2017","unstructured":"Zheng M, Cheng N. Anti-M\u00fcllerian hormone combined with age on ovarian reserve function based on the number of basic antral follicles Evaluation value. Fujian Med J. 2017;39:94\u20136.","journal-title":"Fujian Med J"},{"key":"1524_CR3","first-page":"1","volume":"3","author":"M Claudia","year":"2020","unstructured":"Claudia M, Valentina LP, Fausta S, Scaruff P, Remorgida V, Anserini P. Influence of age on response to controlled ovarian stimulation in women with low levels of serum antiM\u00fcllerian hormone. Gynecol Endocrinol. 2020;3:1\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"1524_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2399\/prn.18.0262004","volume":"26","author":"B AydoganMathyk","year":"2018","unstructured":"AydoganMathyk B, Aslan\u00c7etin B. Maternal serum anti-M\u00fcllerian hormone levels in pregnant women with gestational diabetes. Perinat J. 2018;26(2):74\u20137.","journal-title":"Perinat J"},{"key":"1524_CR5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1055\/a-0840-3817","volume":"79","author":"TU Gorkem","year":"2019","unstructured":"Gorkem TU, Togrul C. Is there a need to alter the timing of anti-m\u00fcllerian hormone measurement during the menstrual cycle? Geburtshilfe Frauenheilkd. 2019;79:731\u20137.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"5","key":"1524_CR6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","volume":"82","author":"A Hazout","year":"2004","unstructured":"Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimullerian hormone\/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004;82(5):1323\u20139.","journal-title":"Fertil Steril"},{"issue":"11","key":"1524_CR7","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","volume":"20","author":"T Eldar-Geva","year":"2005","unstructured":"Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod. 2005;20(11):3178\u201383.","journal-title":"Hum Reprod"},{"key":"1524_CR8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","volume":"103","author":"R Tal","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, et al. Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015;103:119-130.e113.","journal-title":"Fertil Steril."},{"key":"1524_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.32677\/IJCR.2017.v03.i03.016","volume":"3","author":"JH Zhu","year":"2017","unstructured":"Zhu JH. Acupuncture treatment for infertility due to low Anti-M\u00fcllerian hormone levels. Indian J Case Rep. 2017;3:159\u201360.","journal-title":"Indian J Case Rep"},{"key":"1524_CR10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1210\/clinem\/dgac039","volume":"107","author":"IC Marcelle","year":"2022","unstructured":"Marcelle IC. Evaluation of female fertility\u2014AMH and ovarian reserve testing. J Clin Endocrinol Metab. 2022;107:1510\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1524_CR11","first-page":"221","volume":"3","author":"T Yamanouchi","year":"2020","unstructured":"Yamanouchi T, Matsuda H, Ohtake M, Ogata Y, Aikawa Y, Hashiyada Y. in vitro-matured oocyte with\/without super-stimulation, and in vivo-matured oocyte influence the timing of cleavage in early embryo and oxygen consumption of blastocyst after IVF in Japanese Black Cow. Reprod Fertil Dev. 2020;3:221.","journal-title":"Reprod Fertil Dev"},{"key":"1524_CR12","volume-title":"A textbook of in vitro fertilization and assisted reproduction","author":"PR Brinsden","year":"1999","unstructured":"Brinsden PR. A textbook of in vitro fertilization and assisted reproduction. New York: The Parthenon Publishing Group Inc.; 1999."},{"key":"1524_CR13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.fertnstert.2019.07.918","volume":"112","author":"SI Seckin","year":"2019","unstructured":"Seckin SI, Seckin TA, Goldstein KP. Preoperative serum anti-mullerian hormone levels in women with ovarian endometriosis compared to women with peritoneal endometriosis. Fertil Steril. 2019;112:316\u20137.","journal-title":"Fertil Steril"},{"key":"1524_CR14","first-page":"352","volume":"5","author":"LH Gao","year":"2015","unstructured":"Gao LH, Cai WW. Clinical study on the relationship between anti-M\u00fcllerian hormone and age and its prediction of ovarian aging. Chin J Obstet Gynecol. 2015;5:352\u20135.","journal-title":"Chin J Obstet Gynecol"},{"key":"1524_CR15","doi-asserted-by":"publisher","unstructured":"Nizar BM. Significant of Antimullerian Hormone [AMH] test for women infertility. JOJ Case Stud. 2017:1(3):1\u20133. https:\/\/doi.org\/10.19080\/jojcs.2017.01.555565.","DOI":"10.19080\/jojcs.2017.01.555565"},{"key":"1524_CR16","first-page":"492","volume":"38","author":"H Wang","year":"2017","unstructured":"Wang H, Ruan X, et al. Clinical predictive value of anti-M\u00fcllerian hormone and inhibin B in polycystic ovary syndrome. J Cap Med Univ. 2017;38:492\u20136.","journal-title":"J Cap Med Univ"},{"key":"1524_CR17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/aogs.12886","volume":"95","author":"M Depmann","year":"2016","unstructured":"Depmann M, Van Disseldorp J, Broer SL, Eijkemans MJ, Laven JS, Visser JA, De Rijke YB, Mol BW, Broekmans FJ. Fluctuations in anti-M\u00fcllerian hormone levels throughout the menstrual cycle parallel fluctuations in the antral follicle count: a cohort study. Acta Obstet Gynecol Scand. 2016;95:820\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1524_CR18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","volume":"20","author":"R Fanchin","year":"2005","unstructured":"Fanchin R, Taieb J, Daniel H, Lozano M, Ducot B, Frydman R, Bouyer J. High reprodueibility of serum anti-Mullerian hormone measurements suggests a multistaged follieular seeretion and strengthens its role in the assessment of ovarian follieular status. Hum Reprod. 2005;20:923\u20137.","journal-title":"Hum Reprod"},{"key":"1524_CR19","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-16-0522","author":"MW Pankurst","year":"2017","unstructured":"Pankurst MW. A putative role for anti-Mullerian hormone(AMH) in optimising ovarian reserve expenditure. J Endocrinol. 2017. https:\/\/doi.org\/10.1530\/JOE-16-0522.","journal-title":"J Endocrinol"},{"key":"1524_CR20","first-page":"331","volume":"10","author":"EO Ak\u0131n","year":"2018","unstructured":"Ak\u0131n EO, Aycan Z. Evaluation of the ovarian reserve in adolescents with Hashimoto\u2019s thyroiditis using serum anti-m\u00fcllerian hormone Levels. J Clin Res Pediatr Endocrinol. 2018;10:331\u20135.","journal-title":"J Clin Res Pediatr Endocrinol."},{"key":"1524_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12978-015-0053-4","volume":"12","author":"MM Aghsaa","year":"2015","unstructured":"Aghsaa MM, Tarafdari AM. Optimal cutoff value of basal anti-Mullerian hormone in Iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation. Reprod Health. 2015;12:85.","journal-title":"Reprod Health"},{"key":"1524_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.fertnstert.2009.07.1355","volume":"92","author":"F AbdelHafez","year":"2019","unstructured":"AbdelHafez F, Bedaiwy MA, Desai N, Falcone T, Goldfarb J. Assessment of follicular fluid levels of anti-Mullerian hormone in patients undergoing IVF\/ICSI. Fertil Steril. 2019;92:177.","journal-title":"Fertil Steril"},{"key":"1524_CR23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s40618-016-0497-6","volume":"39","author":"B Meczekalski","year":"2016","unstructured":"Meczekalski B, Czyzyk A, Kunicki M, Podfigurna-Stopa A, Plociennik L, et al. in women of late reproductive age:the role of serum anti-Mullerian hormone(AMH) levels in its assessment. J Endocrinol Invest. 2016;39:1259\u201365.","journal-title":"J Endocrinol Invest"},{"key":"1524_CR24","first-page":"2244","volume":"34","author":"P Ciepiela","year":"2019","unstructured":"Ciepiela P, Dul\u0119ba AJ, Kario A, Che\u0142stowski K, Branecka-Wo\u017aniak D, Kurzawa R. Oocyte matched follicular fluid anti-M\u00fcllerian hormone is an excellent predictor of live birth after fresh single embryo transfer. Hum Reprod. 2019;34:2244\u201353.","journal-title":"Hum Reprod"},{"key":"1524_CR25","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","volume":"20","author":"J Pe\u00f1arrubia","year":"2005","unstructured":"Pe\u00f1arrubia J, F\u00e1bregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Juan AV, Balasch J. Basal and stimulation day 5 anti-Mtillerian horInone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin\u2014releasing hormone agonist gona dotropin treatment. Hum Reprod. 2005;20:915\u201322.","journal-title":"Hum Reprod"},{"key":"1524_CR26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12978-021-01298-2","volume":"18","author":"S Liang","year":"2021","unstructured":"Liang S, Chen Y, et al. Prevalence and associated factors of infertility among 20\u201349 year old women in Henan Province. China Reprod Health. 2021;18:254.","journal-title":"China. Reprod Health"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-022-01524-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-022-01524-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-022-01524-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T16:26:18Z","timestamp":1670948778000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-022-01524-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1186\/s12978-022-01524-5","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Ethics Committee of Affiliated Hospital of Southwest Medical University. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conficts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}